# MaxCyte Preliminary Q3 Core Revenue Rises 26% to About $8.1 Million

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/31865
Published: 2026-10-14T14:00:37.000Z
Updated: 2026-10-14T14:00:37.000Z
Section: Business

> The preliminary figure covers MaxCyte’s core business for the third quarter of 2026.

MaxCyte’s preliminary core business revenue rose 26% year over year to about $8.1 million in the third quarter of 2026.

The revenue figure is preliminary and covers MaxCyte’s core business.